Skip to main content
Erschienen in:

06.09.2018 | Original Article

Evaluation of a comprehensive geriatric assessment tool in geriatric cancer patients undergoing adjuvant chemotherapy: a pilot study

verfasst von: Rama Koneru, Orit Freedman, Manon Lemonde, Jane Froese

Erschienen in: Supportive Care in Cancer | Ausgabe 5/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

It is recommended to use comprehensive geriatric assessment (CGA) in clinical oncology practice to improve care for geriatric cancer patients and to identify medical and social issues that may need further intervention. The purpose of this pragmatic pilot study was to evaluate the effectiveness of the Hurria et al. CGA in cancer patients 70 years of age or older undergoing adjuvant chemotherapy, as well as the feasibility of integrating it into a busy clinic practice and the psychosocial impact on these patients.

Method

Twenty-five patients were recruited. Descriptive analysis was performed via a geriatric assessment questionnaire completed by the participants prior to their first adjuvant chemotherapy treatment and during follow-up, 2 to 6 weeks after last treatment. Additionally, study staff performed a geriatric healthcare assessment at both time points.

Results

The results of this pilot study show that administration is feasible despite some challenges. Administration of a CGA in a clinic setting presented some logistical issues with regard to time and space available in clinic. Analysis of patient data indicated only minor variations in patient domains from pre-chemo to post-chemo confirming previous research. Participants expressed gratitude for the extra time spent with them at a stressful time in their lives.

Conclusion

Further information regarding the usefulness of a comprehensive geriatric assessment with regard to improving treatment selection, identifying undetected medical problems, and avoiding toxicity will be obtained if the administration of comprehensive geriatric questionnaires is incorporated into the clinic setting and considered into the allocated time for staff workload.
Literatur
3.
Zurück zum Zitat Fried LP, Storer DJ, King DE, Lodder F (1991) Diagnosis of illness presentation in the elderly. J Am Geriatr Soc 39:117–123CrossRefPubMed Fried LP, Storer DJ, King DE, Lodder F (1991) Diagnosis of illness presentation in the elderly. J Am Geriatr Soc 39:117–123CrossRefPubMed
5.
Zurück zum Zitat Puts MTE, Hardt J, Monette V, Girre E, Springall E, Alibhai SM (2012) Use of geriatric assessment for older adults in the oncology setting: a systematic review. J Natl Cancer Inst 104(15):1134–1164CrossRefPubMedCentral Puts MTE, Hardt J, Monette V, Girre E, Springall E, Alibhai SM (2012) Use of geriatric assessment for older adults in the oncology setting: a systematic review. J Natl Cancer Inst 104(15):1134–1164CrossRefPubMedCentral
6.
Zurück zum Zitat Devons CAJ (2002) Comprehensive geriatric assessment: making the most of the aging years. Current Opinion Clinical Nutrition Metabolic Care 5(1):19–24CrossRef Devons CAJ (2002) Comprehensive geriatric assessment: making the most of the aging years. Current Opinion Clinical Nutrition Metabolic Care 5(1):19–24CrossRef
7.
Zurück zum Zitat Hurria A, Lachs MS, Cohen HJ, Muss HB, Kornblith AB (2006) Geriatric assessment for oncologists: rationale and future directions. Crit Rev Oncol Hematol 59(3):211–217CrossRefPubMed Hurria A, Lachs MS, Cohen HJ, Muss HB, Kornblith AB (2006) Geriatric assessment for oncologists: rationale and future directions. Crit Rev Oncol Hematol 59(3):211–217CrossRefPubMed
8.
Zurück zum Zitat Hurria A, Cirrincione CT, Muss HB, Kornblith AB, Barry W, Artz AS, Schmieder L, Ansari R, Tew WP, Weckstein D, Kirshner J, Togawa K, Hansen K, Katheria V, Stone R, Galinsky I, Postiglione J, Cohen HJ (2011) Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401. J Clin Oncol 29(10):1290–1296CrossRefPubMedPubMedCentral Hurria A, Cirrincione CT, Muss HB, Kornblith AB, Barry W, Artz AS, Schmieder L, Ansari R, Tew WP, Weckstein D, Kirshner J, Togawa K, Hansen K, Katheria V, Stone R, Galinsky I, Postiglione J, Cohen HJ (2011) Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401. J Clin Oncol 29(10):1290–1296CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Piccirillo JF, Vlahiotis A, Barrett LB, Flood KL, Spitznagel EL, Steyerberg EW (2008) The changing prevalence of comorbidity across the age spectrum. Crit Rev Oncol Hematol 67(2):124–132CrossRefPubMedPubMedCentral Piccirillo JF, Vlahiotis A, Barrett LB, Flood KL, Spitznagel EL, Steyerberg EW (2008) The changing prevalence of comorbidity across the age spectrum. Crit Rev Oncol Hematol 67(2):124–132CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Balducci L, Colloca G, Cesari M, Gambassi G (2010) Assessment and treatment of elderly patients with cancer. Surg Oncol 19:117–123CrossRefPubMed Balducci L, Colloca G, Cesari M, Gambassi G (2010) Assessment and treatment of elderly patients with cancer. Surg Oncol 19:117–123CrossRefPubMed
11.
Zurück zum Zitat Decoster L, Van Puyvelde K, Mohile S, Wedding U, Basso U, Colloca G, Rostoft S, Overcash J, Wildier H, Steer C, Kimmick G, Kanesvaran R, Luciani A, Terret C, Hurria A, Kenis C, Audisio R, Extermann M (2015) Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations. Ann Oncol 26:288–300. https://doi.org/10.1093/annonc/mdu210 CrossRefPubMed Decoster L, Van Puyvelde K, Mohile S, Wedding U, Basso U, Colloca G, Rostoft S, Overcash J, Wildier H, Steer C, Kimmick G, Kanesvaran R, Luciani A, Terret C, Hurria A, Kenis C, Audisio R, Extermann M (2015) Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations. Ann Oncol 26:288–300. https://​doi.​org/​10.​1093/​annonc/​mdu210 CrossRefPubMed
12.
Zurück zum Zitat Bellera, CA, Rainfray M, Mathoulin-Pelissier S, Mertens C, Delva F, Fonck M, Soubeyran PL (2012) Screening older cancer patients: first evaluation of the G-8 geriatric screening tool. Annals of Oncology : mdr587, 23, 2166, 2172 Bellera, CA, Rainfray M, Mathoulin-Pelissier S, Mertens C, Delva F, Fonck M, Soubeyran PL (2012) Screening older cancer patients: first evaluation of the G-8 geriatric screening tool. Annals of Oncology : mdr587, 23, 2166, 2172
13.
Zurück zum Zitat Hurria A, Gupta S, Zauderer M, Zuckerman EL, Cohen HJ, Muss H, Rodin M, Panageas KS, Holland JC, Saltz L, Kris MG, Noy A, Gomez J, Jakubowski A, Hudis C, Kornblith AB (2005) Developing a cancer-specific geriatric assessment. Cancer 104(9):1998–2005CrossRefPubMed Hurria A, Gupta S, Zauderer M, Zuckerman EL, Cohen HJ, Muss H, Rodin M, Panageas KS, Holland JC, Saltz L, Kris MG, Noy A, Gomez J, Jakubowski A, Hudis C, Kornblith AB (2005) Developing a cancer-specific geriatric assessment. Cancer 104(9):1998–2005CrossRefPubMed
14.
Zurück zum Zitat Puts MTE, Santos B, Hardt J, Monette J, Girre V, Atenafu EG, et al. An update of a systematic on the use of geriatric assessment for older adults in oncology. Ann Oncol 2013; In press Puts MTE, Santos B, Hardt J, Monette J, Girre V, Atenafu EG, et al. An update of a systematic on the use of geriatric assessment for older adults in oncology. Ann Oncol 2013; In press
15.
Zurück zum Zitat Syme R, Stiles C (2012) Promoting nursing research and innovation by staff nurses. Appl Nurs Res 25(1):17–24CrossRefPubMed Syme R, Stiles C (2012) Promoting nursing research and innovation by staff nurses. Appl Nurs Res 25(1):17–24CrossRefPubMed
16.
Zurück zum Zitat Roxburgh M (2005) An exploration of factors which constrain nurses from research participation. J Clin Nurs 15:535–545 2006CrossRef Roxburgh M (2005) An exploration of factors which constrain nurses from research participation. J Clin Nurs 15:535–545 2006CrossRef
Metadaten
Titel
Evaluation of a comprehensive geriatric assessment tool in geriatric cancer patients undergoing adjuvant chemotherapy: a pilot study
verfasst von
Rama Koneru
Orit Freedman
Manon Lemonde
Jane Froese
Publikationsdatum
06.09.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 5/2019
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-018-4448-y

Neu im Fachgebiet Onkologie

Chemoembolisation bei HCC frühzeitig mit Checkpoint-Inhibitor kombinieren?

Beim hepatozellulären Karzinom scheint sich eine neue Therapieoption abzuzeichnen: In zwei randomisierten Studien ließ sich das progressionsfreie Überleben mit der Kombination aus Chemoembolisation, Checkpoint-Inhibitor und antiangiogener Therapie signifikant verbessern. 

Antikörper-Wirkstoff-Konjugat hält Brusttumoren langfristig in Schach

Erreichen Frauen mit HER2-positivem Mammakarzinom nach einer neoadjuvanten Therapie keine Komplettremission, bietet eine Therapie mit Trastuzumab Emtansin langfristig Vorteile: Die Sterberate ist im Vergleich zu einer Trastuzumab-Therapie um ein Drittel reduziert.

Studie zur HIFU bei Prostatakrebs lässt viele Fragen offen

Führt eine HIFU-Ablation beim Prostatakarzinom im Vergleich mit einer radikalen Prostatektomie zu ähnlichen onkologischen, aber besseren funktionalen Ergebnissen? Interimsdaten der französischen HIFI-Studie sind uneindeutig. In einem Kommentar zur Studie werden zumindest drei allgemeine Erkenntnisse herausgearbeitet.

Bei Achalasie auf Candidiasis der Speiseröhre achten!

Bei Achalasie-Betroffenen sollte man immer auch auf Candida-Infektionen achten, warnen Forschende aus Rotterdam. In ihrer Studie ließ die Pilzinfektion das Risiko für ein Ösophaguskarzinom massiv steigen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.